Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787904 · ClinicalTrials.gov registry record
Role of T-cells in Post-Menopausal Osteoporosis
A clinical trial, sponsored by Atlanta VA Medical Center.
- Completed
- Registry status
- 19
- Enrollment target
NCT00787904: Completed study, sponsored by Atlanta VA Medical Center.
NCT00787904 is a clinical trial that has completed, run by Atlanta VA Medical Center. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00787904 has completed, sponsored by Atlanta VA Medical Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is an observational study of women undergoing surgical menopause to determine whether T-cells play an important role in the etiology of post-menopausal osteoporosis. Subjects will examined before and after surgery and followed over a two year period to determine the biology of T-cells during this study period.
Primary Outcome
(Please note to reviewer, CD3 positivity indicates a T-cell, the title is correct)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-12 |
What the finished NCT00787904 record still lists
NCT00787904 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00787904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00787904 about?
NCT00787904 is a clinical study titled "Role of T-cells in Post-Menopausal Osteoporosis". This is an observational study of women undergoing surgical menopause to determine whether T-cells play an important role in the etiology of post-menopausal osteoporosis. Subjects will examined before and after surgery and followed over a two year period to determine the biology of T-cells during th...
What is the current status of trial NCT00787904?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2006-12. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT00787904?
This trial is sponsored by Atlanta VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia